Samantha Semenkow
Stock Analyst at Citigroup
(0.81)
# 3,771
Out of 4,855 analysts
43
Total ratings
28.57%
Success rate
-21.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Downgrades: Neutral | $10 → $1.5 | $1.69 | -11.24% | 3 | May 27, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $17 → $13 | $2.48 | +424.19% | 3 | May 16, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $8 → $4 | $1.42 | +181.69% | 3 | May 15, 2025 | |
| ARGX argenx SE | Maintains: Buy | $796 → $803 | $585.97 | +37.04% | 6 | May 9, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $60 | $21.13 | +183.96% | 1 | May 2, 2025 | |
| BIOA BioAge Labs | Maintains: Neutral | $7 → $5 | $4.47 | +11.86% | 3 | Mar 24, 2025 | |
| VYGR Voyager Therapeutics | Initiates: Buy | $12 | $3.54 | +238.98% | 1 | Dec 2, 2024 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $27 → $31 | $25.87 | +19.83% | 2 | Aug 9, 2024 | |
| SANA Sana Biotechnology | Maintains: Buy | $8 → $15 | $2.84 | +428.17% | 2 | Aug 9, 2024 | |
| SNSE Sensei Biotherapeutics | Reinstates: Buy | $4 | $0.34 | +1,062.12% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $2.68 | +422.39% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $1.91 | +685.34% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $72 | $46.88 | +53.58% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $16.77 | +198.15% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $18.58 | +201.48% | 3 | Aug 9, 2023 |
Prime Medicine
May 27, 2025
Downgrades: Neutral
Price Target: $10 → $1.5
Current: $1.69
Upside: -11.24%
Cabaletta Bio
May 16, 2025
Maintains: Buy
Price Target: $17 → $13
Current: $2.48
Upside: +424.19%
Allogene Therapeutics
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.42
Upside: +181.69%
argenx SE
May 9, 2025
Maintains: Buy
Price Target: $796 → $803
Current: $585.97
Upside: +37.04%
Structure Therapeutics
May 2, 2025
Initiates: Buy
Price Target: $60
Current: $21.13
Upside: +183.96%
BioAge Labs
Mar 24, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $4.47
Upside: +11.86%
Voyager Therapeutics
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $3.54
Upside: +238.98%
Catalyst Pharmaceuticals
Aug 9, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $25.87
Upside: +19.83%
Sana Biotechnology
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $2.84
Upside: +428.17%
Sensei Biotherapeutics
Jun 3, 2024
Reinstates: Buy
Price Target: $4
Current: $0.34
Upside: +1,062.12%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $2.68
Upside: +422.39%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $1.91
Upside: +685.34%
Dec 8, 2023
Initiates: Buy
Price Target: $72
Current: $46.88
Upside: +53.58%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $16.77
Upside: +198.15%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $18.58
Upside: +201.48%